These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 26673292)
1. [Results of comprehensive management of patients with chronic lower limb ischaemia using gene-engineering technologies of angiogenesis stimulation (Part 2)]. Gavrilenko AV; Voronov DA Angiol Sosud Khir; 2015; 21(4):29-35. PubMed ID: 26673292 [TBL] [Abstract][Full Text] [Related]
2. [Results of comprehensive management of patients with chronic lower limb ischaemia using gene-engineering technologies of angiogenesis stimulation (Part 1)]. Gavrilenko AV; Voronov DA Angiol Sosud Khir; 2015; 21(3):7-15. PubMed ID: 26355918 [TBL] [Abstract][Full Text] [Related]
3. [Five-year results of treating patients with chronic lower limb ischaemia by means of gene engineering]. Chervyakov YV; Staroverov IN; Vlasenko ON; Bozo IY; Isaev AA; Deev RV Angiol Sosud Khir; 2016; 22(4):38-44. PubMed ID: 27935878 [TBL] [Abstract][Full Text] [Related]
4. [The use of genetic angiogenesis inductors in surgical treatment of chronic lower limb ischemia]. Gavrilenko AV; Voronov DA; Bochkov NP Khirurgiia (Mosk); 2013; (2):25-9. PubMed ID: 23503379 [TBL] [Abstract][Full Text] [Related]
5. [Therapeutic angiogenesis in treatment of patients with chronic obliterating diseases of lower limb arteries]. Cherviakov IuV; Staroverov IN; Nersesian EG; Isaev AA; Deev RV Angiol Sosud Khir; 2012; 18(3):19-27. PubMed ID: 23059603 [TBL] [Abstract][Full Text] [Related]
6. [Remote results of treatment of patients with chronic lower-limb ischaemia by means of indirect revascularization and gene therapy]. Chervyakov YV; Staroverov IN; Vlasenko ON; Nersesyan EG; Isaev AA; Deev RV Angiol Sosud Khir; 2016; 22(1):29-34, 36-7. PubMed ID: 27100535 [TBL] [Abstract][Full Text] [Related]
7. [Combination of reconstructive vascular operations with gene-engineering technologies of angiogenesis stimulation: a present-day policy aimed at improving the remote results of treating patients with lower limb chronic ischaemia]. Gavrilenko AV; Voronov DA; Konstantinov BA; Bochkov NP Angiol Sosud Khir; 2008; 14(4):49-53. PubMed ID: 19791552 [TBL] [Abstract][Full Text] [Related]
8. [Efficacy of using VEGF165 gene in comprehensive treatment of patients with stage 2A-3 lower limb chronic ischaemia]. Deev RV; Bozo IIa; Mzhavanadze ND; Nersesian EG; Chukhralia OV; Shval'b PG; Cherviakov IuV; Staroverov IN; Kalinin RE; Voronov DA; Gavrilenko AV; Isaev AA Angiol Sosud Khir; 2014; 20(2):38-48. PubMed ID: 24961325 [TBL] [Abstract][Full Text] [Related]
9. Insights into gene therapy for critical limb ischemia: the devil is in the details. Madonna R; Rokosh G Vascul Pharmacol; 2012 Aug; 57(1):10-4. PubMed ID: 22580542 [TBL] [Abstract][Full Text] [Related]
10. [Effect of drug therapy for chronic obliterating diseases of lower-limb arteries on the state of the microcirculatory bed]. Uchkin IG; Zudin AM; Bagdasarian AG; Fedorovich AA Angiol Sosud Khir; 2014; 20(2):27-36. PubMed ID: 24961324 [TBL] [Abstract][Full Text] [Related]
11. [Genetic engineering technologies of stimulating angiogenesis as an innovation trend in angiology and vascular surgery]. Gavrilenko AV; Voronov DA Angiol Sosud Khir; 2015; 21(2):7-10, 12-4. PubMed ID: 26035559 [TBL] [Abstract][Full Text] [Related]
12. Clinical Safety and Preliminary Efficacy of Plasmid pUDK-HGF Expressing Human Hepatocyte Growth Factor (HGF) in Patients with Critical Limb Ischemia. Cui S; Guo L; Li X; Gu Y; Fu J; Dong L; Song H; Chen X; Lu Y; Hu C; Xiao F; Zhu D; Wu Z; Zhang Q Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):494-501. PubMed ID: 26122834 [TBL] [Abstract][Full Text] [Related]
13. [Use of drug-free methods of treatment in comprehensive therapy of patients with stage II chronic lower limb ischaemia]. Makarov IV; Lukashova AV Angiol Sosud Khir; 2016; 22(2):21-6. PubMed ID: 27336329 [TBL] [Abstract][Full Text] [Related]